跳至主要内容
临床试验/NCT02833545
NCT02833545已完成4 期

Safety and Efficacy of Intra-articular Ozone Injections for Knee Osteoarthritis

Rabin Medical Center0 个研究点目标入组 50 人开始时间: 2016年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
50
主要终点
Improvement in VAS Pain intensity

研究概览

简要总结

Prospective, Interventional, Non-Randomized, Open Label, Single Group Assignment, Single Center.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Sequential
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

the outcome assessor was not aware of the therapy administered

入排标准

年龄范围
55 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 55 to 79 years of age
  • Symptomatic Knee osteoarthritis
  • VAS pain intensity is at least 40 mm on a 100 mm scale
  • Must be physically and mentally willing and able to comply with post-operative rehabilitation and routinely schedule clinical and radiographic visits.

排除标准

  • Any known tumor of the ipsilateral knee.
  • Any known infection of the treated knee.
  • Osteoarthritis of the operated knee Kelgren Lawrence < grade
  • Chemotherapy treatment in the past 12 months.
  • Patients who are sensitive to ozone.
  • Pregnant women, or breastfeeding women.
  • Evidence of any significant systemic disease (such as but not limited to HIV infection, hepatitis infection or HTLV infection), known coagulopathies, that might compromise the Subject's welfare.
  • Substance abuse or alcohol abuse.
  • Participation in other clinical trials in parallel to this study.

研究组 & 干预措施

OZONE

Experimental

injection of ozone gas

干预措施: Ozone gas (Device)

control

Active Comparator

injeciton of steroids intra articularly

干预措施: Steroid injection (Drug)

结局指标

主要结局

Improvement in VAS Pain intensity

时间窗: 6 months

The outcome measure will be measured according to patient response to the question: during the last week what was your average pain intensity. The response will be measured in millimeters as marked on a 10 cm long line. No pain equals 0 mm and maximal possible pain equals 100mm

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

DROR ROBINSON

Head Orthopedic Research Unit

Rabin Medical Center

相似试验